Search
CervoMed Inc
CRVOAdd to Watchlist
3.690USD
+0.590+19.03%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
49.91MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of CervoMed Inc is 8.00, ranking 166 out of 387 in the Biotechnology & Medical Research industry. The average price target is 20.00, with a high of 31.00 and a low of 15.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
19.500
Target Price
+529.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
CervoMed Inc
CRVO
7
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is CervoMed Inc's price target?
Analysts forecast that CervoMed Inc's price target is USD 20.00, with the highest forecast at USD 31.00 and the lowest forecast at USD 15.00.
How have CervoMed IncCRVO's recent earnings per share performed?
The market expectation was USD -0.86, while CervoMed IncCRVO's earnings per share (EPS) for the previous quarter was USD -0.87. EPS for the next quarter is expected at USD -0.80.
What is the analyst rating for CervoMed Inc?
Based on the ratings of CervoMed Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.